← Back to CEO Rankings
👤

Joaquin Duato

Johnson & Johnson (JNJ)
Healthcare
🏢 CEO since 2022 · 4 years
+51.5%
1-Year Stock Performance
$72.0M
2024 Compensation
😊 Positive
News Sentiment

Employment History

Company Role Years
Johnson & Johnson CEO 2022–
★ Current
Johnson & Johnson Senior roles incl. Vice Chairman 1989–2022
Joined 1989 in Spain

Education

Institution Degree Year
ESADE MBA 1985

Latest News

Limited recent coverage. Includes older articles for context.
Yahoo Finance Singapore
neutral

J&J CEO sends a clear message on the obesity drug boom - Yahoo Finance Singapore

J&J CEO sends a clear message on the obesity drug boom  Yahoo Finance Singapore...

Jun 24, 2026 Read More →
Bloomberg
neutral

J&J Takes a Pass on Obesity Drugs to Focus Efforts on Cancer - Bloomberg

J&J Takes a Pass on Obesity Drugs to Focus Efforts on Cancer  Bloomberg...

Jun 17, 2026 Read More →
WSJ
neutral

J&J CEO on the Quest to Cure Cancer - WSJ

J&J CEO on the Quest to Cure Cancer  WSJ...

Jun 17, 2026 Read More →
Tech Times
neutral

Johnson Johnson Myeloma Data Cuts Death Risk 53%: Cure Within Decade Gains Ground - Tech Times

Johnson Johnson Myeloma Data Cuts Death Risk 53%: Cure Within Decade Gains Ground  Tech Times...

Jun 17, 2026 Read More →
qz.com
neutral

Johnson & Johnson CEO says curing certain cancers within a decade is a realistic goal - qz.com

Johnson & Johnson CEO says curing certain cancers within a decade is a realistic goal  qz.com...

Jun 16, 2026 Read More →